Number of the records: 1
skúšanie klinické, fáza II, ako téma
SYS d017322 LBL 00000cz--a2200000n--4500 005 20250606214455.4 008 920513|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 $d BA006 065 $a E05.318.372.250.250.210 065 $a N05.715.360.330.250.250.210 065 $a N06.850.520.450.250.250.210 066 $a 01 $c 03 089 $a 615.036 150 $a skúšanie klinické, fáza II, ako téma $x CL $x EC $x ES $x HI $x IS $x LJ $x MT $x PX $x SN $x ST $x VE $2 slo 450 $w v $a pokusy klinické, druhá fáza, ako téma $2 slo 450 $w v $a testy klinické, druhá fáza, ako téma $2 slo 450 $w v $a štúdie klinické, fáza II, ako téma $2 slo 665 $a 2008(1993) $2 eng 665 $a Clinical Trials (1980-1992) $2 eng 665 $a Drug Evaluation (1980-1992) $2 eng 680 9-
$i Works about studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries. $2 eng 680 $a for general design, methodology, economics, etc. of phase II clinical trials; a different heading CLINICAL TRIAL, PHASE II is used for reports of a specific phase II clinical trial $2 eng 750 -2
$a Clinical Trials, Phase II as Topic $2 eng 980 $x M
Number of the records: 1